|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01696 SISRAM MED
Nominal 
3.490 +0.010 (+0.287%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | 2.961% | 4.050% | 5.389% | 7.400% | 6.496% |
| ROAE (%) | 4.029% | 5.484% | 7.133% | 9.644% | 8.513% |
| Return on Capital Employed (%) | 3.451% | 4.725% | 5.997% | 8.448% | 6.997% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | 58.888% | 62.066% | 61.099% | 57.049% | 56.699% |
| EBITDA Margin (%) | 13.131% | 14.747% | 14.926% | 16.510% | 18.935% |
| Pre-tax Profit Margin (%) | 7.814% | 9.321% | 10.334% | 12.481% | 14.160% |
| Net Profit Margin (%) | 5.205% | 7.197% | 8.767% | 11.332% | 10.617% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | 2.600 X | 2.610 X | 2.916 X | 3.127 X | 3.562 X |
| Quick Ratio (X) | 1.722 X | 1.761 X | 2.003 X | 2.195 X | 2.793 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | 23.366% | 22.713% | 23.468% | 22.206% | 23.863% |
| Total Debt / Total Assets (%) | 7.874% | 6.887% | 7.283% | 7.441% | 7.851% |
| Net Debt / Total Assets (%) | -2.924% | -4.310% | -4.225% | -6.021% | -21.021% |
| Total Debt / Shareholders' Funds (%) | 10.785% | 9.310% | 9.879% | 9.595% | 10.349% |
| Long Term Debt / Shareholders' Funds (%) | 7.391% | 7.327% | 7.858% | 7.593% | 7.766% |
| Net Debt / Shareholders' Funds (%) | -4.005% | -5.826% | -5.730% | -7.764% | -27.709% |
| Net Cash / (Debt) ($) | 19.220M | 27.033M | 25.919M | 33.452M | 111.441M |
| Net Cash / (Debt) per share ($) | 0.041 | 0.058 | 0.055 | 0.072 | 0.239 |
| Total Debt / Capital Employed (%) | 9.393% | 8.124% | 8.507% | 8.695% | 9.320% |
| Interest Coverage Ratio (X) | 9.798 X | 14.255 X | 18.989 X | 26.500 X | 21.784 X |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | 211.793 Day | 222.658 Day | 202.743 Day | 166.560 Day | 145.256 Day |
| Receivables Turnover (Day) | 86.591 Day | 85.844 Day | 83.218 Day | 77.356 Day | 72.168 Day |
| Payables Turnover (Day) | 18.128 Day | 11.167 Day | 10.836 Day | 13.568 Day | 13.929 Day |
| Remarks: | Real time quote last updated: 25/03/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD 19,016 |
| %Change | -24.317% |
| EPS / (LPS) | USD 0.041 |
| NBV Per Share ($) | USD 1.025 |